Programmed death-1 ligands-transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibit both the alloresponse and the GAD65-reactive lymphocyte response

Clinical and Experimental Immunology

Volumn 151, Issue 1, 2008, Pages 86-93

  He, F R ^a   Zhu, H F ^a   Huang, H ^a   Dai, Y D ^b   Shen, X ^a   Wang, M ^a   Li, L ^a   Xing, W ^a   Shen, G X ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Dendritic cell; Glutamic acid decarboxylase 65; Lymphocyte proliferation; Programmed death 1 ligands

Indexed keywords

GLUTAMATE DECARBOXYLASE 65; INTERLEUKIN 10; LIGAND; PROGRAMMED DEATH 1 LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DC2.4 CELL LINE; DENDRITIC CELL; DOWN REGULATION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CELL PROLIFERATION; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; ENDOCYTOSIS; GLUTAMATE DECARBOXYLASE; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-10; ISOANTIGENS; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; TRANSFECTION; TRANSGENES;

EID: 36849017514     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03546.x     Document Type: Article

References (29)

1. Ravanan R, Wong SF, Morgan NG, Mathieson PW, Smith RM. Inhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse. Clin Exp Immunol 2007 148 : 368 72.
2. Mathis D, Vence L, Benoist C et al. Beta-cell death during progression to diabetes. Nature 2001 414 : 792 8.
3. Gottlie PA, Eisenbarth GS. Insulin-specific tolerance in diabetes. Clin Immunol 2002 102 : 2 11.
4. Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 2001 19 : 131 61.
5. Cooke A, Phillips JM, Parish NM. Tolerance strategies to halt or prevent type 1 diabetes. Nat Immunol 2001 2 : 810 15.
6. Sebastien G, Blandine C, Michel E, Patrice D, Francois R, Benoit B. A new preservation solution increases islet yield and reduces graft immunogenicity in pancreatic islet transplantation. Transplantation 2007 83 : 1397 400.
7. Clarkson MR, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 2005 80 : 555 63.
8. Latchman Y, Wood CR, Chernova T et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001 2 : 261 8.
9. Khoury SJ, Sayegh MH. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 2004 20 : 529 38.
10. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004 199 : 1467 77.
11. Serra P, Amrani A, Yamanouchi J et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 2003 19 : 877 89.
12. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 2005 117 : 289 300.
13. Carreno BM, Clollins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002 20 : 29 53.
14. Goldberg MV, Maris MC, Hipkiss EL et al. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood 2007 110 : 86 92.
15. Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000 192 : 1027 34.
16. Fife BT, Guleria I, Gubbels Bupp M et al. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 2006 27 : 2737 47.
17. Keir ME, Liang SC, Guleria I et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006 17 : 883 95.
18. Ansari MJ, Salama AD, Chitnis T et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 2003 198 : 63 9.
19. Liang SC, Latchman YE, Buhlmann JE et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 2003 33 : 2706 16.
20. Salama AD, Chitnis T, Imitola J et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 2003 198 : 71 8.
21. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997 158 : 2723 30.
22. Steptoe RJ, Ritchie JM, Harrison LC. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone non-obese diabetic mice. J Immunol 2002 168 : 5032 41.
23. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. J Clin Invest 1997 100 : 3173 83.
24. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995 182 : 389 400.
25. Shinya H, Satoru S, Hidetake M, Daiki F, Yasushi U, Yasuharu N. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand1. J Immunol 2005 174 : 1888 97.
26. Kim HK, Guan H, Zu G et al. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals. J Leukoc Biol 2006 79 : 686 95.
27. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002 99 : 2468 76.
28. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001 22 : 394 400.
29. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999 5 : 1365 9.